Guido J. Neels is Director at ENDOLOGIX INC /DE/ (ELGX). They have made 14 open-market trades across 5 companies since 2007, most recently 2026-06-09.
CIK 0001222362
12 open-market purchases totalling $1.2M since 2007, against 2 sales. Across 10 scored buys the stock is down 5.5% at ninety days, and 7.3 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 10% | 60% | 40% |
| Avg Move | -6.8% | -0.3% | -5.5% |
| Alpha | -4.9% | -0.9% | -7.3% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELUT | BUY | 2026-01-30 | 2026-02-02 | $1.04 | $21K | -10.3% | +12.3% | -3.8% |
| ELUT | BUY | 2026-01-28 | 2026-01-29 | $1.06 | $32K | -15.9% | +0.9% | -11.5% |
| AXGN | SELL | 2025-06-09 | 2025-06-11 | $10.61 | $43K | +0.8% | +18.1% | +63.1% |
| AXGN | BUY | 2023-08-16 | 2023-08-18 | $6.11 | $61K | +8.3% | -9.0% | -1.7% |
| ELGX | BUY | 2019-04-03 | 2019-04-03 | $6.61 | $300K | -15.0% | -9.1% | +5.5% |
| AXGN | SELL | 2017-11-20 | 2017-11-21 | $19.74 | $22.7M | +1.9% | +6.1% | +5.9% |
| ELGX | BUY | 2017-05-19 | 2017-05-23 | $4.32 | $86K | -2.5% | -1.0% | -12.2% |
| ELGX | BUY | 2016-11-18 | 2016-11-22 | $7.69 | $100K | -6.3% | -5.3% | -13.1% |
| ELGX | BUY | 2015-11-03 | 2015-11-03 | $9.32 | $103K | -6.9% | +1.5% | -24.8% |
| ENTL | BUY | 2015-02-03 | 2015-02-04 | $17.00 | $255K | -6.0% | +3.4% | +3.4% |
| ELGX | BUY | 2014-11-04 | 2014-11-05 | $11.21 | $112K | -6.9% | +1.5% | +1.5% |
| ELGX | BUY | 2011-02-28 | 2011-03-02 | $5.92 | $101K | -6.9% | +1.5% | +1.5% |
| BPUR | BUY | 2007-11-01 | 2007-11-06 | $0.79 | $8K | N/A | N/A | N/A |
| BPUR | BUY | 2007-07-18 | 2007-07-19 | $0.55 | $3K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| BPUR |
| 27,000 |
| — |
| Total | $5.1M |
Shares reported on the most recent Form 4, priced at the 2026-06-11 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.